Pomalidomide with dexamethasone in relapsed/refractory multiple myeloma with renal impairment
A novel WINDOW of opportunity for young mantle cell lymphoma patients
Using ponatinib to treat highly resistant chronic myeloid leukemia, results from a Phase I trial
Michael J. Mauro
What is the potential of daratumumab in combination therapy for myeloma?
Potential second-line treatment for indolent lymphoma